home / stock / kod / kod news

KOD News and Press, Kodiak Sciences Inc From 08/08/19

Stock Information
Company Name: Kodiak Sciences Inc
Stock Symbol: KOD
Market: NASDAQ
Website: kodiak.com
Menu
KOD KOD Quote KOD Short KOD News KOD Articles KOD Message Board
Get KOD Alerts

News, Short Squeeze, Breakout and More Instantly...
KOD - Kodiak Sciences to Present at Wedbush PacGrow Healthcare Conference

PALO ALTO, Calif. , Aug. 8, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that management will present at the Wedbush PacGrow H...
KOD - Kodiak Sciences Announces Positive Interim Data from Ongoing Phase 1b Clinical Study of KSI-301, a Novel Anti-VEGF Antibody Biopolymer Conjugate for Treatment of Wet AMD, Diabetic Eye Disease, and Retinal Vein Occlusion, at the American Society of Retina

PALO ALTO, Calif. , July 27, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced positive interim results from the ongoing Phase 1b ...

KOD - Kodiak Sciences Announces Upcoming Presentation at American Society of Retina Specialists (ASRS) 2019 Annual Meeting

PALO ALTO, Calif. , July 24, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that data from the ongoing KSI-301 clinical study wi...

KOD - Kodiak Sciences to Present at the Jefferies 2019 Healthcare Conference

PALO ALTO, Calif. , May 30, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that management will present at the Jefferies 2019 ...
KOD - Kodiak Sciences beats by $0.10

Kodiak Sciences (NASDAQ: KOD ): Q1 GAAP EPS of -$0.21 beats by $0.10 . More news on: Kodiak Sciences Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

KOD - Kodiak Sciences Announces First Quarter 2019 Financial Results and Recent Business Highlights

PALO ALTO, Calif. , May 15, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical-stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today reported business highlights and financial results for the firs...

KOD - Kodiak Sciences to Present at the Bank of America Merrill Lynch Health Care Conference 2019

PALO ALTO, Calif. , May 9, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that management will present at the Bank of America Me...
KOD - Kodiak Sciences Announces Presentations at ARVO 2019 Annual Meeting

PALO ALTO, Calif. , April 25, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that presentations on its research will be made at ...

KOD - Automakers, Macau Names And CinemaCon Action (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

KOD - Stocks To Watch: Automakers, Macau Names And CinemaCon Action

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. China's Vice Premier Liu plans to travel to the U.S. next week in what could be ano...
Previous 10 Next 10